Stephanie Gaulding has spent over 25 years working with quality management systems and validation program management in the pharmaceutical, biotech, medical device, and related life science industries. She develops and delivers efficient and sustainable quality management systems assuring compliance with global regulatory requirements and industry best practices to help start-up and industry-leading clients pass regulatory inspections and achieve their desired results. She will be speaking at CPHI’s upcoming webinar series called “The Biotech’s Guide for CDMO Selection” on March 23, 2023.
A continuous challenge that stands in our way is the ever-growing cost of bringing new drugs to market. This year, biopharma companies will continue their efforts to optimize the “total cost of ownership” associated with developing, manufacturing, and commercializing their products. This will lead to an increased focus on not just the function but also the value of outsourced partnerships.
This has led biopharma companies to look for third-party experts who do more than fill an internal skill gap or enable an in-house team to focus on core competencies. These customers are increasingly looking for providers who deliver a strategic, value-adding mix of specialized services, customized solutions, and efficient operations—one that spans as much of the value chain as possible.
Join our latest CPHI Webinar, where our experts will discuss the importance of choosing a CDMO and why is essential in getting it right the first time.
The Biotech’s Guide for CDMO Selection
Date: March 23rd, 2023
Time: 4pm CET / 10am EST
Length: 60 minutes
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
22320 Foothill Blvd. Suite 330, Hayward CA 94541